bluebird bio: The Appealing Decision to Separate its Severe Genetic Disease and Oncology Businesses into Independent Publicly-Traded Firms

bluebird bio Decision to Separate its Businesses bluebird bio ( BLUE )  will retain focus on its severe genetic disease ( SGD ) and will launch its oncology business ( Oncology Newco ) as a new entity...